A propensity score-matched TriNetX analysis compared outcomes after robotic and conventional laparoscopic inguinal hernia repair in adults with chronic kidney disease (CKD). Following matching, 1,693 patients were included in each group for the one-month analysis.
At one month, recorded acute kidney injury (AKI) was significantly more frequent following robotic repair, occurring in approximately 5.0% versus 2.9% after laparoscopic repair, corresponding to a reported hazard ratio of 1.74. Early major adverse cardiovascular events were also more frequently recorded in the robotic cohort.
The AKI signal persisted at six months. Interestingly, postoperative laboratory measurements of renal function appeared somewhat more favorable in the robotic group, creating a discordance between coded AKI events and biochemical renal outcomes. The investigators appropriately caution that differences in patient surveillance and ascertainment—particularly within academic centers performing higher volumes of robotic surgery—could contribute to this finding.
Surgical Relevance
Patients with CKD have limited renal physiological reserve and may be particularly vulnerable to pneumoperitoneum, altered renal perfusion, operative duration, positioning, fluid shifts, nephrotoxic exposure, and perioperative hemodynamic instability.
For hernia surgeons, these findings support careful renal-risk stratification and perioperative monitoring rather than assuming that the use of a robotic platform inherently reduces physiological risk.
Clinical Takeaway: In CKD patients undergoing minimally invasive inguinal hernia repair, platform selection should not replace careful renal protection, hemodynamic optimization, and postoperative renal surveillance.
Source: PubMed – Robotic Versus Laparoscopic Inguinal Hernia Repair in CKD
Robotic Gastric and Colorectal Cancer Surgery Faces a Significant Volume–Cost Challenge
A Japanese real-world economic analysis compared robotic-assisted and laparoscopic curative resections for gastric and colorectal malignancies performed within a general hospital setting.
Despite the technical feasibility of robotic surgery, robotic procedures generated significantly lower gross surgical profit for both gastric and colorectal cancer. A major contributor was robotic maintenance expenditure, estimated to be approximately 17.5 times higher per case. Among the robotic procedures analyzed, low anterior resection was the only subgroup demonstrating positive gross surgical profit.
Using gastric cancer surgery as the reference model, investigators estimated that approximately 233 robotic cases would be required to reach the break-even threshold—around 1.6 times the institution's existing annual robotic case volume.
Surgical Relevance
The sustainability of a robotic surgical program depends on more than acquisition of technology. Case volume, operating-room utilization, maintenance expenditure, consumables, reimbursement, surgeon training concentration, and multidisciplinary use of the platform all influence its economic viability.
This issue is particularly important for general and lower-volume hospitals where robotic case numbers may be insufficient to distribute fixed costs efficiently.
Clinical Takeaway: Successful robotic programs require both clinical value and sufficient institutional volume. Hospitals should evaluate procedure mix, utilization, training strategy, maintenance costs, and reimbursement before expanding robotic oncology services.
Source: PubMed – Cost Analysis of Robotic Gastric and Colorectal Cancer Surgery
Minimally Invasive Liver Resection in Cirrhosis Is Feasible but Carries Increased Perioperative Risk
A systematic review and meta-analysis involving 32 studies and 12,892 patients examined minimally invasive liver resection in patients with and without cirrhosis.
Compared with non-cirrhotic patients, cirrhotic patients experienced higher rates of intraoperative transfusion, conversion to laparotomy, 90-day morbidity, and 90-day mortality. Subgroup analysis identified additional risk associated with more advanced hepatic disease: Child-Pugh B status increased transfusion risk, while portal hypertension was associated with a greater probability of conversion.
An important limitation is that most patients undergoing minimally invasive surgery were highly selected, predominantly Child-Pugh A, and treated at experienced, high-volume hepatobiliary centers. Significant risk of bias across the underlying literature further limits the certainty of comparative conclusions.
Surgical Relevance
Cirrhosis transforms liver resection into a substantially different physiological and technical operation. Portal hypertension, coagulopathy, reduced functional hepatic reserve, collateral vessels, and impaired postoperative regeneration can magnify surgical risk.
Minimally invasive liver resection should therefore remain an expertise-dependent strategy in carefully selected patients, supported by detailed liver-function assessment, portal-hypertension evaluation, blood-loss planning, and readiness for conversion.
Clinical Takeaway: “Minimally invasive” does not mean “low risk” in cirrhotic liver surgery. Patient selection, Child-Pugh status, portal hypertension, blood-loss control, and institutional HPB experience remain decisive.
Source: PubMed – Minimally Invasive Liver Resection in Cirrhosis Meta-Analysis
Cochrane Review Supports Metabolic Surgery Benefits in Obesity With Type 2 Diabetes, but Comparative Certainty Remains Limited
A Cochrane network meta-analysis assessed medium- and long-term outcomes following metabolic and bariatric surgery in adults with obesity and type 2 diabetes. The analysis incorporated 18 studies involving 15,282 participants.
Roux-en-Y gastric bypass (RYGB), one-anastomosis gastric bypass (OAGB), and sleeve gastrectomy generally demonstrated improvements in long-term body weight, waist circumference, HbA1c, and partial diabetes remission compared with lifestyle or medical treatment. Among the procedures evaluated, RYGB showed the most consistent overall signal.
However, evidence concerning complete diabetes remission, serious adverse events, mortality, and long-term diabetes-related complications frequently remained uncertain because of imprecision, study limitations, and risk of bias.
Surgical Relevance
Metabolic surgery provides meaningful long-term metabolic benefits, but the evidence does not justify choosing one operation solely on the basis of a procedure ranking.
Procedure selection should incorporate BMI, diabetes duration, insulin requirement, reflux, eating behavior, nutritional risk, patient preference, adherence potential, and the possibility of future revision.
Clinical Takeaway: Metabolic surgery is an effective component of type 2 diabetes treatment in appropriately selected patients, but procedure choice should remain individualized rather than based on presumed universal superiority of one operation.
Source: PubMed – Cochrane Network Meta-Analysis of Metabolic and Bariatric Surgery
SEMS Followed by Elective Laparoscopic Resection May Improve Recovery in Obstructing Colorectal Cancer
A propensity score-matched retrospective cohort compared self-expandable metallic stent (SEMS) placement followed by elective laparoscopic colorectal resection with emergency surgery for obstructive colorectal cancer.
Following matching, 28 patients were analyzed in each group. The SEMS-to-laparoscopy pathway was associated with a shorter operative duration and faster postoperative gastrointestinal recovery. Overall complications were numerically lower following staged management.
Adjusted analysis also suggested a higher mortality risk following emergency surgery, although the small number of events means this finding requires cautious interpretation and prospective confirmation.
Surgical Relevance
Successful decompression can transform an emergency obstructing colorectal cancer into a more controlled elective operation, potentially allowing preoperative optimization, staging, bowel preparation where appropriate, minimally invasive resection, and improved planning of anastomosis or stoma strategy.
However, SEMS placement introduces its own concerns, including perforation, migration, technical failure, and possible oncological consequences of tumor manipulation or occult perforation. Appropriate endoscopic expertise and multidisciplinary selection are therefore essential.
Clinical Takeaway: In selected obstructing colorectal cancers, SEMS as a bridge to elective laparoscopic surgery may facilitate faster recovery and avoid immediate emergency resection, but patient selection and oncological safety remain critical.
Source: PubMed – SEMS Followed by Elective Laparoscopic Resection Versus Emergency Surgery
Teleassisted Surgical Preceptoring Is Technically Feasible, but Governance Is Now the Major Challenge
A systematic review evaluated teleassisted preceptoring, in which an expert surgeon remotely supervises an operation and may, depending on the technology, have access to reversible remote operative assistance or control.
Only four studies met inclusion criteria: two human clinical series and two experimental porcine studies. Human studies demonstrated meaningful remote expert assistance with relatively low reported complication rates. Experimental data suggested that remote guidance remained reliable with latency below approximately 150 milliseconds, while performance deteriorated as communication delay increased.
The review suggests that the primary obstacles to broader implementation may increasingly be ethical, legal, regulatory, credentialing, economic, cybersecurity, and training-related, rather than purely technological.
Surgical Relevance
Teleassisted preceptoring could potentially extend advanced minimally invasive and robotic expertise to surgeons working far from major specialist centers. It may become particularly valuable for complex procedure mentoring, new robotic platform adoption, structured proctorship, and distributed surgical education.
Clinical implementation, however, requires explicit standards for patient consent, surgeon credentialing, network performance, latency limits, data protection, responsibility for complications, emergency takeover, equipment failure, and outcome auditing.
Clinical Takeaway: Remote surgical mentorship is moving from technical possibility toward clinical reality, but safe adoption requires governance to advance as rapidly as the technology itself.
Source: PubMed – Systematic Review of Teleassisted Surgical Preceptoring
Key Message
The 19 August 2026 evidence update demonstrates that the next phase of minimally invasive surgery is increasingly determined not simply by whether an operation can be performed laparoscopically or robotically, but which patient, platform, institution, and perioperative pathway provide the greatest overall value and safety.
Renal vulnerability must be considered when selecting minimally invasive platforms in CKD; robotic programs require sufficient volume to remain economically sustainable; cirrhotic liver surgery demands stringent selection and high-volume expertise; metabolic surgery provides durable benefits but requires individualized procedure choice; staged decompression may facilitate elective laparoscopy in obstructing colorectal cancer; and teleassisted surgery will require robust governance before widespread clinical adoption.
Better minimally invasive surgery depends on appropriate technology, but even more on patient selection, surgical judgment, institutional expertise, measurable outcomes, and responsible implementation.
